Oncología Traslacional
ONCTRAS
Yonsei University
Seúl, Corea del SurPublikationen in Zusammenarbeit mit Forschern von Yonsei University (3)
2024
-
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Journal of Clinical Oncology, Vol. 42, Núm. 1, pp. 47-58
-
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
New England Journal of Medicine, Vol. 391, Núm. 1, pp. 44-55
2019
-
Oncological outcome of surgical management in patients with recurrent uterine cancer - A multicenter retrospective cohort study - CEEGOG EX01 Trial
International Journal of Gynecological Cancer, Vol. 29, Núm. 4, pp. 711-720